当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析 - 资产负债表

浙江医药

(600216)

  

流通市值:89.43亿  总市值:89.74亿
流通股本:9.62亿   总股本:9.65亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,349,723,417.871,507,694,005.841,404,433,086.351,438,077,266.91
应收票据及应收账款1,314,052,539.591,276,492,383.731,402,484,391.621,297,973,966.65
应收账款1,314,052,539.591,276,492,383.731,402,484,391.621,297,973,966.65
应收款项融资185,807,676.08194,261,062.22207,935,361.85202,546,429.96
预付款项124,209,859.81107,017,048.11107,679,647.0786,547,292.25
其他应收款合计113,839,653.9977,324,549.64119,516,574.0267,353,495.25
存货1,948,530,467.252,070,929,894.141,982,860,271.891,994,514,513.08
其他流动资产93,928,765.54126,394,093.14107,023,277.51120,654,424.38
流动资产平衡项目0000
流动资产合计5,496,405,372.795,768,396,193.415,607,508,474.355,654,960,631.32
非流动资产:
长期股权投资94,856,045.2896,455,394.4485,321,628.1667,878,921.13
其他非流动金融资产78,848,379.4183,355,215.2387,860,045.2576,631,888.27
投资性房地产95,398,023.196,096,938.596,795,853.997,494,769.3
固定资产4,741,555,466.734,562,640,522.914,592,953,479.284,768,092,777.03
在建工程1,045,842,602.461,103,341,208.08994,399,348.75825,705,993.24
使用权资产23,642,038.1623,839,759.9131,095,493.8424,235,203.41
无形资产764,873,529.86785,313,025.75727,567,200.63747,676,154.65
商誉27,906,888.4527,906,888.4527,906,888.4527,906,888.45
长期待摊费用6,898,951.57,550,714.858,280,238.28,854,241.55
递延所得税资产82,328,821.172,893,393.4395,691,881.2277,406,084.3
其他非流动资产134,309,703.6392,840,523.52127,891,775.9255,772,652.42
非流动资产平衡项目0000
非流动资产合计7,096,460,449.686,952,233,585.076,875,763,833.66,777,655,573.75
资产平衡项目0000
资产总计12,592,865,822.4712,720,629,778.4812,483,272,307.9512,432,616,205.07
流动负债:
短期借款200,202,800200,202,80050,063,40050,063,400
应付票据及应付账款1,002,017,602.491,047,523,143.881,044,628,281.861,061,226,508.31
其中:应付票据40,525,974.2230,247,195.8926,495,410.1232,561,801.43
应付账款961,491,628.271,017,275,947.991,018,132,871.741,028,664,706.88
合同负债32,691,955.733,389,712.431,516,863.9361,879,310.12
应付职工薪酬85,185,823.1651,736,477.4395,221,930.87180,601,079.33
应交税费58,455,002.8148,034,103.2866,166,306.15105,505,994.87
其他应付款合计654,805,000.26610,000,262.59554,193,577.11447,978,805.99
应付股利29,971.1829,971.1829,971.1829,971.18
一年内到期的非流动负债535,766,443.15535,775,345.56635,983,069.66550,913,156.54
其他流动负债3,294,125.843,016,791.123,508,586.67,196,234.21
流动负债平衡项目0000
流动负债合计2,572,418,753.412,529,678,636.262,481,282,016.182,465,364,489.37
非流动负债:
长期借款65,068,60065,068,600115,116,700200,186,500
租赁负债479,824.94472,026.127,885,871.5619,943.4
递延收益55,414,939.8954,324,627.3954,218,377.3954,112,127.39
递延所得税负债153,898.481,469,365.391,519,377.552,474,097.55
非流动负债平衡项目0000
非流动负债合计121,117,263.31121,334,618.9178,740,326.44257,392,668.34
负债平衡项目0000
负债合计2,693,536,016.722,651,013,255.162,660,022,342.622,722,757,157.71
所有者权益(或股东权益):
实收资本(或股本)964,975,000964,975,000965,128,000965,128,000
资本公积2,022,041,246.662,016,551,197.021,968,119,318.111,941,160,652.45
减:库存股27,632,43028,199,762.557,692,37557,692,375
其他综合收益208,247.647,985,890.57-4,065,482.59-5,274,168.68
盈余公积1,586,460,146.221,586,460,146.221,586,460,146.221,586,460,146.22
未分配利润4,967,392,447.585,102,360,728.224,943,651,451.494,830,099,602.34
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计9,513,444,658.19,650,133,199.539,401,601,058.239,259,881,857.33
少数股东权益385,885,147.65419,483,323.79421,648,907.1449,977,190.03
股东权益平衡项目0000
股东权益合计9,899,329,805.7510,069,616,523.329,823,249,965.339,709,859,047.36
负债和股东权益合计12,592,865,822.4712,720,629,778.4812,483,272,307.9512,432,616,205.07
公告日期2023-10-262023-08-242023-04-262023-04-26
审计意见(境内)标准无保留意见
TOP↑